Saturday 17 October 2026 Export NCEL’s income statement to Excel — free account

NewcelX Ltd.

NCEL Healthcare Biotechnology

Insiders bought in the last twelve months.

2.50 0.35 −12.28%

Follow NCEL

Alert me

Market cap: $15.3M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+8 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(22.82)	(17.56)	(10.65)	(4.89)
Capital Expenditures Full definition →		(0.04)	—	(0.01)	—
Other line items
Cash ROIC Full definition →		310.68%	(294.81%)	(108.60%)	(68.48%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		—	—	—	0.00%
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.02	4.23	0.04	1.07
Capex/Depreciation Full definition →		(1.67)	0.00	(0.18)	0.00
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	—	0.00	—
Capex to Sales Full definition →		0.00	—	0.00	—

Show all line items

Columns are period end dates